|
Re: Not out of the woods yet with COVID-19
|
6
|
Resverlogix Corp.
|
Feb 19, 2022 03:48PM
|
|
Re: RVX Board Thoughts Mar 18 2022 – Wishful Thinking
|
6
|
Resverlogix Corp.
|
Mar 19, 2022 05:43PM
|
|
Re: we need some info!
|
6
|
Resverlogix Corp.
|
Jun 09, 2021 01:42PM
|
|
Re: Deal or no Deal?
|
6
|
Resverlogix Corp.
|
Jul 23, 2020 11:01AM
|
|
Re: So I was able to finally set up a one on one meeting with...
|
6
|
Resverlogix Corp.
|
Mar 16, 2022 11:55AM
|
|
Re: China- 1 Million daily COVID cases
|
5
|
Resverlogix Corp.
|
Dec 27, 2022 06:18PM
|
|
Re: Form 45-106F1 Report of Exempt Distribution Dec 13, 2021
|
5
|
Resverlogix Corp.
|
Dec 14, 2021 02:38PM
|
|
Re: RVX is warming up!
|
5
|
Resverlogix Corp.
|
Jan 25, 2022 02:58PM
|
|
Re: Resverlogix: The Future of Drug Development, CEO Clip Video
|
5
|
Resverlogix Corp.
|
Dec 16, 2021 05:23PM
|
|
Re: Resverlogix: The Future of Drug Development, CEO Clip Video
|
5
|
Resverlogix Corp.
|
Dec 16, 2021 07:00PM
|
|
Update would be nice
|
5
|
Resverlogix Corp.
|
Sep 27, 2021 03:26PM
|
|
Re: Financing-Move On
|
5
|
Resverlogix Corp.
|
May 05, 2021 04:31PM
|
|
Re: China- 1 Million daily COVID cases
|
5
|
Resverlogix Corp.
|
Dec 30, 2022 10:39AM
|
|
New Variant
|
5
|
Resverlogix Corp.
|
Nov 26, 2021 12:13PM
|
|
Re: Link to 2023 AGM presentation is up
|
5
|
Resverlogix Corp.
|
Jun 22, 2023 12:47PM
|
|
Re: New Apabetalone Fabry Disease Publication
|
5
|
Resverlogix Corp.
|
Apr 29, 2022 01:50PM
|
|
Re: FDA approves "empagliflozin" for reducing risk of cardiovascular death, hospitalization among adult HFpEF patients
|
5
|
Resverlogix Corp.
|
Apr 05, 2022 11:28AM
|
|
Re: RVX Price has nearly doubled in the past two days ...
|
5
|
Resverlogix Corp.
|
Feb 02, 2023 08:19PM
|
|
Potential Suitor
|
4
|
Resverlogix Corp.
|
Sep 11, 2020 10:18PM
|
|
Re: Potential Scope of Indications for Apabetalone (selective BRD/BD inhibition)
|
4
|
Resverlogix Corp.
|
Nov 14, 2022 08:14PM
|
